Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C + metformin + azithromycin + doxycycline for mild to moderate COVID-19
IRCT20200418047121N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ascorbic acid, metformin, azithromycin and doxycycline in coronavirus disease 2019 (COVID-19), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Disease recovery. Started May 2020; status: completed.
02
Drugs
ascorbic acidmetforminazithromycindoxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200418047121N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200418047121N1.